Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07725042

Analyses of Newly Diagnosed HIV Infection in Hong Kong

The goal of the project is to determine the epidemiologic status and changing patterns of HIV infection in Hong Kong. The main question it aims to answer is:

- what is the molecular pattern and burden of HIV-1 infections over the years

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

With the aim of determining the epidemiologic status and changing patterns of HIV infection in Hong Kong, a prospective cohort study is conducted with the objectives of: (a) describing the distribution of HIV-1 subtypes of newly diagnosed infection and their association with transmission routes; (b) characterising the transmission clusters of HIV infection and their dynamicity; and (c) evaluating the community burden of HIV and its changes over time. An epidemiologic cohort database would be established from newly diagnosed HIV infections reported in Hong Kong over a 4-year period. People living with HIV infections are invited to complete a self-administered questionnaire survey to capture data on their behavioural and network profiles prior to infection, supplemented by transcription of relevant clinical record data including CD4/CD8 and viral load measures. Blood sampling would be performed for supporting RNA sequencing. The main outcome measures are the prevalent and temporal changes of epidemiologic profile, molecular network patterns and population viral loads

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • adult of age 18 or above, who are
  • people living with HIV, and
  • attending the service of an HIV specialist clinic in the public service in Hong Kong

Exclusion criteria

  • travelers or visitors who are temporarily staying in Hong Kong
  • prisoners
  • patients with mental illnesses who are unable to make informed decision
  • patients whose HIV diagnosis was made outside Hong Kong and whose treatment have already started.

Treatment and study plan

Primary outcomes

  1. main molecular HIV-1 subtype

    Time frame: from enrollment to the end of the study at 4 years

    Proportion of patients infection with HIV-1 subtype B

  2. main HIV transmission mode

    Time frame: from enrollment to end of study at 4 years

    Proportion of patients who are men who have sex with men

Secondary outcomes

  1. changes in HIV molecular pattern

    Time frame: from enrolment to end of study at 4 years

    Percentage difference in the proportion of patients with HIV-1 subtype B between the last 2 years versus the first 2 years

  2. Change in transmission mode

    Time frame: from enrolment to end of study at 4 years

    Percentage difference in the proportion of patients who are men who have sex with men in the last 2 years versus the first 2 years

Study contacts

Contact information is provided by the study sponsor or research team.

Ngai Sze Wong, PhD

CONTACT

[email protected]

+85222528812

Shui Shan Lee, MD

CONTACT

[email protected]

+85261703177

Sponsors and collaborators

Lead sponsor

Chinese University of Hong Kong

Other

Registry information

Official study title

Combined Epidemiologic and Molecular Network Analyses of Newly Diagnosed HIV Infection in Hong Kong

Important dates

Study start
2024
Primary completion
2029
Study completion
2029
First posted
Jul 24, 2026
Registry last updated
Jul 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.